Verifying…
Home / Drug A–Z / MenQuadfi Vaccine

MenQuadfi Vaccine

NAFDAC Reg. No. A6-100059 · Drug

Registered with NAFDAC — registration activeAs of 6 November 2026 · synced automatically from official sources.
Product
MenQuadfi Vaccine
NAFDAC number
A6-100059
Active ingredient
Meningococcal ACWY conjugate vaccine (MenACWY)
Strength
0.5 mL
Form
Solution for injection
Pack size
0.5 mL
Manufacturer
Not listed
Applicant (holder)
Sanofi-Aventis Nigeria Limited
Approved
20 Oct 2022
Status
Active View on NAFDAC ↗
Registration valid to
24 Aug 2027
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • MenQuadfi Vaccine is on the NAFDAC register with an active registration (A6-100059). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What MenQuadfi Vaccine is used for

From the official U.S. FDA label for meningococcal acwy conjugate vaccine (menacwy), the active ingredient registered with NAFDAC.

What it is used for

Temporarily relieves symptoms of runny nose, fever & cough.**

Purpose

Temporarily relieves symptoms of runny nose, fever & cough.**

Warnings

IF PREGNANT OR BREAST-FEEDING , ask a health care professional before use. KEEP OUT OF THE REACH OF CHILDREN. In case of overdose (or accidental ingestion) get medical help or contact a Poison Control Center right away. Do not use if TAMPER EVIDENT seal is broken or missing.

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of MenQuadfi Vaccine

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About MenQuadfi Vaccine

What is in MenQuadfi Vaccine?

MenQuadfi Vaccine contains Meningococcal ACWY conjugate vaccine (MenACWY) (0.5 mL), as solution for injection, according to its NAFDAC registration record.

Is MenQuadfi Vaccine registered with NAFDAC?

Yes. MenQuadfi Vaccine is listed on the NAFDAC register under registration number A6-100059, and its registration is active as of 6 November 2026.

Has MenQuadfi Vaccine been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches MenQuadfi Vaccine in our automatically synced alert list.

How can I check that my pack of MenQuadfi Vaccine is genuine?

Run a free authenticity scan with the NAFDAC number A6-100059, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is MenQuadfi Vaccine used for?

Temporarily relieves symptoms of runny nose, fever & cough.** (Summarised from the official U.S. FDA label for meningococcal acwy conjugate vaccine (menacwy). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used MenQuadfi Vaccine? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.